Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Dieter Götte"'
Autor:
S. von Vietinghoff, M P Schönermark, I Buchholz, Dieter Götte, Hermann Haller, Peter Rutherford, Philip Spearpoint, A. Deichmann
Publikováno v:
Der Internist. 63:210-216
Zusammenfassung Hintergrund und Zielsetzung Unter dem Begriff der mit antineutrophilen zytoplasmatischen Antikörpern (ANCA) assoziierten Vaskulitis (AAV) wird eine Gruppe seltener, chronischer, durch rezidivierende systemische Entzündungen gekennze
Autor:
Philip Spearpoint, Dieter Götte, Peter Lamprecht, Matthias P. Schönermark, Ina Buchholz, Peter Rutherford, Angelika Deichmann, Bernhard Hellmich
Publikováno v:
Rheumatology. 60:4868-4873
Objective ANCA-associated vasculitides (AAV) are rare, potentially life-threatening autoimmune diseases characterized by systemic inflammation and organ damage. AAV prevalence rates reported in Europe vary considerably and robust data sources are oft
Autor:
Peter Rutherford, Philip Spearpoint, Angelika Deichmann, Ina Buchholz, Bernhard Hellmich, Dieter Götte, Matthias P. Schönermark
Publikováno v:
Gesundheitsökonomie & Qualitätsmanagement. 26:88-92
ZusammenfassungDie wirtschaftliche Belastung durch ANCA-assoziierte Vaskulitiden (AAV), potenziell lebensbedrohliche Autoimmunerkrankungen, wurde mittels einer Versorgungsdatenanalyse untersucht.In dieser retrospektiven Studie wurden anonymisierte, r
Autor:
Peter Rutherford, Dieter Götte
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims ANCA associated vasculitis (AAV) treatment aims to quickly control vasculitis activity and then prevent relapse during the maintenance phase of this long term condition. Patients are at risk from disease and treatment related comp
Autor:
Peter Rutherford, Dieter Götte
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims ANCA associated vasculitis (AAV) is a relapsing remitting long term condition and patients are at risk of organ damage from both active AAV and its therapy in particular high dose and/or prolonged glucocorticoids (GC). The remissi
Autor:
Dieter Götte, Peter Rutherford
Publikováno v:
Poster Presentations.
Background High dose glucocorticoids (GCs) are a component of induction remission and maintenance regimes in ANCA-associated vasculitis (AAV) and are used in other inflammatory disorders. The adverse event (AE) profile of GC is well known and in AAV
Autor:
Peter Rutherford, Dieter Götte
Publikováno v:
Poster Presentations.
Background ANCA-associated vasculitis (AAV) presents clinically with variable severity of disease and current clinical guidelines give varying advice on initial treatment to induce remission. Achieving remission quickly is important to gain disease c
Autor:
Dieter Götte, Peter Rutherford, Matthias Schoenermark, Philip Spearpoint, Angelika Deichmann, Marc Wengler
Publikováno v:
Poster Presentations.
Background ANCA-associated vasculitis AAV is a rare systemic disease, characterized by recurrent episodes of systemic inflammation. It is a severe disease associated with hospitalization, risk of renal failure and a therapy inducing serious side effe
Publikováno v:
Nephrology Dialysis Transplantation. 34
Publikováno v:
Nephrology Dialysis Transplantation. 34